Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001872278 | SCV002123031 | benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359294 | SCV002623418 | uncertain significance | Inborn genetic diseases | 2018-07-23 | criteria provided, single submitter | clinical testing | The p.A1345S variant (also known as c.4033G>T), located in coding exon 1 of the RAI1 gene, results from a G to T substitution at nucleotide position 4033. The alanine at codon 1345 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004743601 | SCV005360094 | likely benign | RAI1-related disorder | 2024-08-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |